Amyloid imaging in depression: a predictor of Alzheimer's disease?

被引：2
|
作者：
Camacho, Valle [1 ]
LLeo, Alberto [2 ,3 ]
机构：
[1] Autonomous Univ Barcelona, Hosp St Pau, Dept Nucl Med, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Dept Neurol, Barcelona, Spain
[3] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2014年 / 41卷 / 04期
关键词：
PITTSBURGH COMPOUND-B; FLORBETAPIR F 18; MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; TASK-FORCE; PET; BETA;
D O I：
10.1007/s00259-014-2741-7
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：711 / 713
页数：3
相关论文
共 50 条
  • [41] Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer's disease
    Aljuhani, Manal
    Ashraf, Azhaar
    Edison, Paul
    BRAIN COMMUNICATIONS, 2024, 6 (06)
  • [42] Cortical florbetapir-PET amyloid load in prodromal Alzheimer's disease patients
    Saint-Aubert, Laure
    Barbeau, Emmanuel J.
    Peran, Patrice
    Nemmi, Federico
    Vervueren, Celine
    Mirabel, Helene
    Payoux, Pierre
    Hitzel, Anne
    Bonneville, Fabrice
    Gramada, Raluca
    Tafani, Mathieu
    Vincent, Christian
    Puel, Michele
    Dechaumont, Sophie
    Chollet, Francois
    Pariente, Jeremie
    EJNMMI RESEARCH, 2013, 3 : 1 - 22
  • [43] Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue
    Ni, Ruiqing
    Gillberg, Per-Goran
    Bergfors, Assar
    Marutle, Amelia
    Nordberg, Agneta
    BRAIN, 2013, 136 : 2217 - 2227
  • [44] Amyloid Imaging with PET in Early Alzheimer Disease Diagnosis
    Rowe, Christopher C.
    Villemagne, Victor L.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (03) : 377 - +
  • [45] Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer's Disease and Other Tauopathies
    Maschio, Cinzia
    Ni, Ruiqing
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [46] Understanding the Amyloid Hypothesis in Alzheimer's Disease
    Paroni, Giulia
    Bisceglia, Paola
    Seripa, Davide
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (02) : 493 - 510
  • [47] Surface tension and intrinsic amyloid fluorescence of serum and cerebrospinal fluid samples in Alzheimer's disease
    Gazova, Zuzana
    Bednarikova, Zuzana
    Bartos, Ales
    Klaschka, Jan
    Kristofikova, Zdenka
    BIOMARKERS IN MEDICINE, 2019, 13 (04) : 267 - 277
  • [48] Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease
    Vilkaite, Gabriele
    Vogel, Jacob
    Mattsson-Carlgren, Niklas
    CELL REPORTS MEDICINE, 2024, 5 (09)
  • [49] Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers
    Perneczky, Robert
    Alexopoulos, Panagiotis
    Kurz, Alexander
    TRENDS IN MOLECULAR MEDICINE, 2014, 20 (01) : 8 - 15
  • [50] PET amyloid-beta imaging in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Benzinger, Tammie L. S.
    Morris, John C.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
12345